Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132422) titled 'Application of Image-Guided Technology in the Interventional Diagnosis and Treatment of Breast Diseases' on Sept. 14.

Study Type: Diagnostic test

Study Design: Diagnostic test for accuracy

Primary Sponsor: Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine

Condition: Suspicious breast lesions that are occult on conventional imaging and only visible on MRI

Intervention: Gold Standard:Final pathology from MRI-guided biopsy served as the reference standard, with malignancies confirmed by surgical histopathology.For benign biopsy cases without surgery, MRI follow-up (>=6 months) wi...